Cryogenic OGS Limited (BOM:544440)
India · Delayed Price · Currency is INR 319.00
+14.00 (4.59%)
At close: Jul 31, 2026
Cryogenic OGS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 408.22 | 329.05 | 242.54 | 220.22 | 233.3 |
Other Revenue | - | -0 | - | - | - |
| 408.22 | 329.05 | 242.54 | 220.22 | 233.3 | |
Revenue Growth | 24.06% | 35.67% | 10.14% | -5.61% | 2.28% |
Cost of Revenue | 211.12 | 189.37 | 135.61 | 121.7 | 151.26 |
Gross Profit | 197.11 | 139.68 | 106.93 | 98.51 | 82.05 |
Selling, General & Admin | 27.69 | 20.1 | 16.87 | 14.67 | 17.41 |
Other Operating Expenses | 56.57 | 39.97 | 22.48 | 27.23 | 21.17 |
Operating Expenses | 89.57 | 65.27 | 45 | 48.67 | 43.44 |
Operating Income | 107.54 | 74.41 | 61.93 | 49.84 | 38.61 |
Interest Expense | -1.01 | -0.24 | -0.86 | -1.08 | -0.75 |
Interest & Investment Income | 16.11 | 8.47 | 7.61 | 4.68 | 5.41 |
Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0.02 | -0.13 | 0.01 |
Other Non Operating Income (Expenses) | -0.12 | -0.36 | -0.34 | -0.73 | -0.29 |
EBT Excluding Unusual Items | 122.52 | 82.3 | 68.37 | 52.59 | 42.99 |
Gain (Loss) on Sale of Investments | - | - | 1.62 | 2.19 | 1.28 |
Gain (Loss) on Sale of Assets | 12.4 | 0.26 | 1.22 | - | - |
Pretax Income | 134.92 | 82.68 | 71.2 | 54.78 | 44.27 |
Income Tax Expense | 33.09 | 21.78 | 17.75 | 14.01 | 11.45 |
Net Income | 101.83 | 60.9 | 53.45 | 40.77 | 32.81 |
Net Income to Common | 101.83 | 60.9 | 53.45 | 40.77 | 32.81 |
Net Income Growth | 67.21% | 13.94% | 31.12% | 24.23% | 14.64% |
Shares Outstanding (Basic) | 13 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 13 | 11 | 11 | 11 | 11 |
Shares Change | 26.14% | - | - | - | - |
EPS (Basic) | 7.69 | 5.80 | 5.09 | 3.88 | 3.13 |
EPS (Diluted) | 7.69 | 5.80 | 5.09 | 3.88 | 3.13 |
EPS Growth | 32.56% | 13.94% | 31.19% | 24.15% | 14.64% |
Free Cash Flow | 50.24 | 16.62 | 15.26 | 14.43 | 6.46 |
Free Cash Flow Per Share | 3.79 | 1.58 | 1.45 | 1.38 | 0.62 |
Gross Margin | 48.28% | 42.45% | 44.09% | 44.73% | 35.17% |
Operating Margin | 26.34% | 22.61% | 25.54% | 22.63% | 16.55% |
Profit Margin | 24.94% | 18.51% | 22.04% | 18.51% | 14.06% |
Free Cash Flow Margin | 12.31% | 5.05% | 6.29% | 6.55% | 2.77% |
EBITDA | 113.31 | 79.62 | 67.58 | 56.58 | 43.45 |
EBITDA Margin | 27.76% | 24.20% | 27.86% | 25.69% | 18.63% |
D&A For EBITDA | 5.77 | 5.21 | 5.64 | 6.73 | 4.85 |
EBIT | 107.54 | 74.41 | 61.93 | 49.84 | 38.61 |
EBIT Margin | 26.34% | 22.61% | 25.54% | 22.63% | 16.55% |
Effective Tax Rate | 24.53% | 26.34% | 24.93% | 25.58% | 25.87% |
Revenue as Reported | 424.35 | 337.91 | 256.74 | 227.09 | 240 |
Advertising Expenses | 0.79 | - | - | - | 0.01 |